Status:
COMPLETED
Video-assisted Hyperthermic Pleural Chemoperfusion vs Talc Pleurodesis for Refractory Malignant Pleural Effusions.
Lead Sponsor:
Theagenio Cancer Hospital
Conditions:
Safety of Intervention
Efficacy of Intervention
Eligibility:
All Genders
Up to 75 years
Phase:
NA
Brief Summary
Aim of this study is to compare two methods of pleurodesis for refractory malignant pleural effusions, in terms of safety and efficacy.
Detailed Description
The study compares prospectively two groups of patients with refractory maignant pleural effusion. Group A consists of patients undergoing video-assisted hyperthermic pleural chemoperfusion (with a pu...
Eligibility Criteria
Inclusion
- Recurrent symptomatic malignant pleural effusion
- No prior intrapleural therapy
- Abscence of bronchial obstruction or fibrosis preventing lung reexpansion
- No systemic chemotherapy immediately prior to or during the first 30-day interval following pleurodesis
Exclusion
- Poor Karnofsky Performance Status
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01409551
Start Date
August 1 2011
End Date
November 1 2014
Last Update
November 17 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thoracic Surgery Department, Theagenio Cancer Hospital
Thessaloniki, Greece, 54007